Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- FAB25301P - Provider product page
- Provider
- Novus Biologicals
- Product name
- Mouse Monoclonal CD155/PVR Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human CD155/PVR in direct ELISAs and Western blots.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 100 Tests
- Storage
- Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
Submitted references Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma.
Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing.
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.
The cell surface proteome of human mesenchymal stromal cells.
Cytotoxicity of activated natural killer cells against pediatric solid tumors.
Niu C, Jin H, Li M, Zhu S, Zhou L, Jin F, Zhou Y, Xu D, Xu J, Zhao L, Hao S, Li W, Cui J
Oncotarget 2017 Jan 24;8(4):5954-5964
Oncotarget 2017 Jan 24;8(4):5954-5964
Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing.
Kearney CJ, Ramsbottom KM, Voskoboinik I, Darcy PK, Oliaro J
Oncoimmunology 2016 Aug;5(8):e1196308
Oncoimmunology 2016 Aug;5(8):e1196308
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.
Parrish C, Scott GB, Migneco G, Scott KJ, Steele LP, Ilett E, West EJ, Hall K, Selby PJ, Buchanan D, Varghese A, Cragg MS, Coffey M, Hillmen P, Melcher AA, Errington-Mais F
Leukemia 2015 Sep;29(9):1799-810
Leukemia 2015 Sep;29(9):1799-810
The cell surface proteome of human mesenchymal stromal cells.
Niehage C, Steenblock C, Pursche T, Bornhäuser M, Corbeil D, Hoflack B
PloS one 2011;6(5):e20399
PloS one 2011;6(5):e20399
Cytotoxicity of activated natural killer cells against pediatric solid tumors.
Cho D, Shook DR, Shimasaki N, Chang YH, Fujisaki H, Campana D
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Aug 1;16(15):3901-9
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Aug 1;16(15):3901-9
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Detection of CD155/PVR in HUVEC Human Cells by Flow Cytometry. HUVEC human umbilical vein endothelial cells were stained with Mouse Anti-Human CD155/PVR PE-conjugated Monoclonal Antibody (Catalog # FAB25301P, filled histogram) or isotype control antibody (Catalog # IC002P, open histogram). View our protocol for Staining Membrane-associated Proteins.